title: Effect of the 5-HT2 antagonist ketanserin on the ECT-induced prolactin release.
authors.affiliation: Department of Psychiatry, University of British Columbia, Vancouver, Canada.
authors.forename: A P
authors.initials: AP
authors.lastname: Zis
authors.forename: H K
authors.initials: HK
authors.lastname: Manji
authors.forename: R A
authors.initials: RA
authors.lastname: Remick
authors.forename: B E
authors.initials: BE
authors.lastname: Grant
authors.forename: C M
authors.initials: CM
authors.lastname: Clark
mesh_terms: D000328:Adult; D000368:Aged; D001921:Brain / Q000187:drug effects; D002986:Clinical Trials as Topic; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D007650:Ketanserin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011388:Prolactin / Q000097:blood*; D011985:Receptors, Serotonin / Q000187:drug effects*
chemical_list: D011985:Receptors, Serotonin; D011388:Prolactin; D007650:Ketanserin